{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T18:56:08Z","timestamp":1784141768225,"version":"3.55.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:00:00Z","timestamp":1736467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:00:00Z","timestamp":1736467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Syst Biol Appl"],"DOI":"10.1038\/s41540-024-00485-8","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T08:48:06Z","timestamp":1736498886000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Transformer-based modeling of Clonal Selection and Expression Dynamics reveals resistance mechanisms in breast cancer"],"prefix":"10.1038","volume":"11","author":[{"given":"Nathan D","family":"Maulding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7233-661X","authenticated-orcid":false,"given":"Ciara","family":"Metcalfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua M","family":"Stuart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1337-7598","authenticated-orcid":false,"given":"Marc","family":"Hafner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,10]]},"reference":[{"key":"485_CR1","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nature22794","volume":"546","author":"SM Shaffer","year":"2017","unstructured":"Shaffer, S. M. et al. Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance. Nature 546, 431\u2013435 (2017).","journal-title":"Nature"},{"key":"485_CR2","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.cell.2018.06.025","volume":"174","author":"F Rambow","year":"2018","unstructured":"Rambow, F. et al. Toward minimal residual disease-directed therapy in melanoma. Cell 174, 843\u2013855.e19 (2018).","journal-title":"Cell"},{"key":"485_CR3","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.cels.2020.03.004","volume":"10","author":"L Schuh","year":"2020","unstructured":"Schuh, L. et al. Gene networks with transcriptional bursting recapitulate rare transient coordinated high expression states in cancer. Cell Syst. 10, 363\u2013378.e12 (2020).","journal-title":"Cell Syst."},{"key":"485_CR4","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.cell.2010.04.020","volume":"141","author":"A Roesch","year":"2010","unstructured":"Roesch, A. et al. A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell 141, 583\u2013594 (2010).","journal-title":"Cell"},{"key":"485_CR5","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.cell.2010.02.027","volume":"141","author":"SV Sharma","year":"2010","unstructured":"Sharma, S. V. et al. A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell 141, 69\u201380 (2010).","journal-title":"Cell"},{"key":"485_CR6","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.cell.2011.07.026","volume":"146","author":"PB Gupta","year":"2011","unstructured":"Gupta, P. B. et al. Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell 146, 633\u2013644 (2011).","journal-title":"Cell"},{"key":"485_CR7","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.cell.2020.07.003","volume":"182","author":"SM Shaffer","year":"2020","unstructured":"Shaffer, S. M. et al. Memory sequencing reveals heritable single-cell gene expression programs associated with distinct cellular behaviors. Cell 182, 947\u2013959.e17 (2020).","journal-title":"Cell"},{"key":"485_CR8","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/s41587-021-00837-3","volume":"39","author":"BL Emert","year":"2021","unstructured":"Emert, B. L. et al. Variability within rare cell states enables multiple paths towards drug resistance. Nat. Biotechnol. 39, 865\u2013876 (2021).","journal-title":"Nat. Biotechnol."},{"key":"485_CR9","doi-asserted-by":"publisher","first-page":"13679","DOI":"10.1073\/pnas.1712064115","volume":"114","author":"Y Su","year":"2017","unstructured":"Su, Y. et al. Single-cell analysis resolves the cell state transition and signaling dynamics associated with melanoma drug-induced resistance. Proc. Natl. Acad. Sci. USA 114, 13679\u201313684 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"485_CR10","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","volume":"15","author":"I Dagogo-Jack","year":"2018","unstructured":"Dagogo-Jack, I. & Shaw, A. T. Tumour heterogeneity and resistance to cancer therapies. Nat. Rev. Clin. Oncol. 15, 81\u201394 (2018).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"485_CR11","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/nm.3841","volume":"21","author":"HC Bhang","year":"2015","unstructured":"Bhang, H. C. et al. Studying clonal dynamics in response to cancer therapy using high-complexity barcoding. Nat. Med. 21, 440\u2013448 (2015).","journal-title":"Nat. Med."},{"key":"485_CR12","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/s41586-018-0744-4","volume":"564","author":"BA Biddy","year":"2018","unstructured":"Biddy, B. A. et al. Single-cell mapping of lineage and identity in direct reprogramming. Nature 564, 219\u2013224 (2018).","journal-title":"Nature"},{"key":"485_CR13","doi-asserted-by":"publisher","first-page":"eaaw3381","DOI":"10.1126\/science.aaw3381","volume":"367","author":"C Weinreb","year":"2020","unstructured":"Weinreb, C., Rodriguez-Fraticelli, A., Camargo, F. D. & Klein, A. M. Lineage tracing on transcriptional landscapes links state to fate during differentiation. Science 367, eaaw3381 (2020).","journal-title":"Science"},{"key":"485_CR14","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/s43018-021-00222-8","volume":"2","author":"C Gutierrez","year":"2021","unstructured":"Gutierrez, C. et al. Multifunctional barcoding with ClonMapper enables high-resolution study of clonal dynamics during tumor evolution and treatment. Nat. Cancer 2, 758\u2013772 (2021).","journal-title":"Nat. Cancer"},{"key":"485_CR15","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41586-021-03796-6","volume":"596","author":"Y Oren","year":"2021","unstructured":"Oren, Y. et al. Cycling cancer persister cells arise from lineages with distinct programs. Nature 596, 576\u2013582 (2021).","journal-title":"Nature"},{"key":"485_CR16","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nature20777","volume":"541","author":"KL Frieda","year":"2017","unstructured":"Frieda, K. L. et al. Synthetic recording and in situ readout of lineage information in single cells. Nature 541, 107\u2013111 (2017).","journal-title":"Nature"},{"key":"485_CR17","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41587-020-0614-0","volume":"39","author":"C Umkehrer","year":"2021","unstructured":"Umkehrer, C. et al. Isolating live cell clones from barcoded populations using CRISPRa-inducible reporters. Nat. Biotechnol. 39, 174\u2013178 (2021).","journal-title":"Nat. Biotechnol."},{"key":"485_CR18","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1016\/j.immuni.2021.03.012","volume":"54","author":"L Tian","year":"2021","unstructured":"Tian, L. et al. Clonal multi-omics reveals Bcor as a negative regulator of emergency dendritic cell development. Immunity 54, 1338\u20131351.e9 (2021).","journal-title":"Immunity"},{"key":"485_CR19","doi-asserted-by":"publisher","first-page":"100215","DOI":"10.1016\/j.xgen.2022.100215","volume":"3","author":"J Leighton","year":"2023","unstructured":"Leighton, J., Hu, M., Sei, E., Meric-Bernstam, F. & Navin, N. E. Reconstructing mutational lineages in breast cancer by multi-patient-targeted single-cell DNA sequencing. Cell Genom. 3, 100215 (2023).","journal-title":"Cell Genom."},{"key":"485_CR20","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41586-020-2503-6","volume":"583","author":"AE Rodriguez-Fraticelli","year":"2020","unstructured":"Rodriguez-Fraticelli, A. E. et al. Single-cell lineage tracing unveils a role for TCF15 in haematopoiesis. Nature 583, 585\u2013589 (2020).","journal-title":"Nature"},{"key":"485_CR21","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/s43588-023-00427-0","volume":"3","author":"M Pillai","year":"2023","unstructured":"Pillai, M., Hojel, E., Jolly, M. K. & Goyal, Y. Unraveling non-genetic heterogeneity in cancer with dynamical models and computational tools. Nat. Comput. Sci. 3, 301\u2013313 (2023).","journal-title":"Nat. Comput. Sci."},{"key":"485_CR22","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41587-021-01005-3","volume":"40","author":"MT Chang","year":"2022","unstructured":"Chang, M. T. et al. Identifying transcriptional programs underlying cancer drug response with TraCe-seq. Nat. Biotechnol. 40, 86\u201393 (2022).","journal-title":"Nat. Biotechnol."},{"key":"485_CR23","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41586-023-06342-8","volume":"620","author":"Y Goyal","year":"2023","unstructured":"Goyal, Y. et al. Diverse clonal fates emerge upon drug treatment of homogeneous cancer cells. Nature 620, 651\u2013659 (2023).","journal-title":"Nature"},{"key":"485_CR24","doi-asserted-by":"publisher","first-page":"100247","DOI":"10.1016\/j.xgen.2022.100247","volume":"3","author":"LP Richman","year":"2023","unstructured":"Richman, L. P., Goyal, Y., Jiang, C. L. & Raj, A. ClonoCluster: a method for using clonal origin to inform transcriptome clustering. Cell Genom. 3, 100247 (2023).","journal-title":"Cell Genom."},{"key":"485_CR25","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/s43018-023-00577-0","volume":"4","author":"TJ Hagenbeek","year":"2023","unstructured":"Hagenbeek, T. J. et al. An allosteric pan-TEAD inhibitor blocks oncogenic YAP\/TAZ signaling and overcomes KRAS G12C inhibitor resistance. Nat. Cancer 4, 812\u2013828 (2023).","journal-title":"Nat. Cancer"},{"key":"485_CR26","doi-asserted-by":"publisher","first-page":"998339","DOI":"10.3389\/fcell.2022.998339","volume":"10","author":"M Cerezo","year":"2022","unstructured":"Cerezo, M., Sun, X. & Shen, S. Editorial: Non-genetic adaptive drug resistance in cancer. Front. Cell Dev. Biol. 10, 998339 (2022).","journal-title":"Front. Cell Dev. Biol."},{"key":"485_CR27","doi-asserted-by":"publisher","first-page":"11841","DOI":"10.1021\/acs.jmedchem.1c00847","volume":"64","author":"J Liang","year":"2021","unstructured":"Liang, J. et al. GDC-9545 (Giredestrant): a potent and orally bioavailable selective estrogen receptor antagonist and degrader with an exceptional preclinical profile for ER+ breast cancer. J. Med. Chem. 64, 11841\u201311856 (2021).","journal-title":"J. Med. Chem."},{"key":"485_CR28","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/nmeth.3853","volume":"13","author":"M Hafner","year":"2016","unstructured":"Hafner, M., Niepel, M., Chung, M. & Sorger, P. K. Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs. Nat. Methods 13, 521\u2013527 (2016).","journal-title":"Nat. Methods"},{"key":"485_CR29","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.cell.2019.06.026","volume":"178","author":"J Guan","year":"2019","unstructured":"Guan, J. et al. Therapeutic ligands antagonize estrogen receptor function by impairing its mobility. Cell 178, 949\u2013963.e18 (2019).","journal-title":"Cell"},{"key":"485_CR30","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.3390\/jcm4121952","volume":"4","author":"B Zhou","year":"2015","unstructured":"Zhou, B., Moodie, A., Blanchard, A. A. A., Leygue, E. & Myal, Y. Claudin 1 in breast cancer: new insights. J. Clin. Med. 4, 1960\u20131976 (2015).","journal-title":"J. Clin. Med."},{"key":"485_CR31","first-page":"139","volume":"20","author":"S Morohashi","year":"2007","unstructured":"Morohashi, S. et al. Decreased expression of claudin-1 correlates with recurrence status in breast cancer. Int. J. Mol. Med. 20, 139\u2013143 (2007).","journal-title":"Int. J. Mol. Med."},{"key":"485_CR32","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/modpathol.2012.187","volume":"26","author":"S Lu","year":"2013","unstructured":"Lu, S. et al. Claudin expression in high-grade invasive ductal carcinoma of the breast: correlation with the molecular subtype. Mod. Pathol. 26, 485\u2013495 (2013).","journal-title":"Mod. Pathol."},{"key":"485_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15574-5","volume":"11","author":"C Fougner","year":"2020","unstructured":"Fougner, C., Bergholtz, H., Norum, J. H. & S\u00f8rlie, T. Re-definition of claudin-low as a breast cancer phenotype. Nat. Commun. 11, 1787 (2020).","journal-title":"Nat. Commun."},{"key":"485_CR34","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.7150\/jca.47344","volume":"12","author":"Y Liu","year":"2021","unstructured":"Liu, Y. et al. Long non-coding RNA SNHG25 promotes epithelial ovarian cancer progression by up-regulating COMP. J. Cancer 12, 1660\u20131668 (2021).","journal-title":"J. Cancer"},{"key":"485_CR35","doi-asserted-by":"publisher","first-page":"100687","DOI":"10.1016\/j.ctarc.2023.100687","volume":"35","author":"Z Zhiyu","year":"2023","unstructured":"Zhiyu, Z., Qi, Z., Zhen, S., Jianglei, Z. & Jun, O. Small nucleolar RNA host gene 25 is a long non-coding RNA helps diagnose and predict outcomes in prostate cancer. Cancer Treat. Res. Commun. 35, 100687 (2023).","journal-title":"Cancer Treat. Res. Commun."},{"key":"485_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-021-00906-w","volume":"14","author":"Y He","year":"2021","unstructured":"He, Y., Xu, S., Qi, Y., Tian, J. & Xu, F. Long noncoding RNA SNHG25 promotes the malignancy of endometrial cancer by sponging microRNA-497-5p and increasing FASN expression. J. Ovarian Res. 14, 163 (2021).","journal-title":"J. Ovarian Res."},{"key":"485_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-022-05040-z","volume":"13","author":"H Zeng","year":"2022","unstructured":"Zeng, H. et al. SNHG25 facilitates SNORA50C accumulation to stabilize HDAC1 in neuroblastoma cells. Cell Death Dis. 13, 1\u201313 (2022).","journal-title":"Cell Death Dis."},{"key":"485_CR38","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1002\/iub.2501","volume":"73","author":"A Biagioni","year":"2021","unstructured":"Biagioni, A. et al. Small nucleolar RNA host genes promoting epithelial-mesenchymal transition lead cancer progression and metastasis. IUBMB Life 73, 825\u2013842 (2021).","journal-title":"IUBMB Life"},{"key":"485_CR39","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 1, 417\u2013425 (2015).","journal-title":"Cell Syst."},{"key":"485_CR40","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1093\/bioinformatics\/btq134","volume":"26","author":"A Altmann","year":"2010","unstructured":"Altmann, A., Tolo\u015fi, L., Sander, O. & Lengauer, T. Permutation importance: a corrected feature importance measure. Bioinformatics 26, 1340\u20131347 (2010).","journal-title":"Bioinformatics"},{"key":"485_CR41","first-page":"920","volume":"12","author":"K Wu","year":"2003","unstructured":"Wu, K. et al. Stage-specific expression of breast cancer-specific gene gamma-synuclein. Cancer Epidemiol. Biomark. Prev. 12, 920\u2013925 (2003).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"485_CR42","doi-asserted-by":"publisher","first-page":"27435","DOI":"10.18632\/oncotarget.25415","volume":"9","author":"L Tian","year":"2018","unstructured":"Tian, L., Zhao, Y., Truong, M.-J., Lagadec, C. & Bourette, R. P. Synuclein gamma expression enhances radiation resistance of breast cancer cells. Oncotarget 9, 27435\u201327447 (2018).","journal-title":"Oncotarget"},{"key":"485_CR43","doi-asserted-by":"publisher","first-page":"3795","DOI":"10.3892\/mmr.2015.3799","volume":"12","author":"Q Zhuang","year":"2015","unstructured":"Zhuang, Q., Liu, C., Qu, L. & Shou, C. Synuclein-\u03b3 promotes migration of MCF7 breast cancer cells by activating extracellular-signal regulated kinase pathway and breaking cell-cell junctions. Mol. Med. Rep. 12, 3795\u20133800 (2015).","journal-title":"Mol. Med. Rep."},{"key":"485_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2007-8-5-r76","volume":"8","author":"JI Herschkowitz","year":"2007","unstructured":"Herschkowitz, J. I. et al. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol. 8, R76 (2007).","journal-title":"Genome Biol."},{"key":"485_CR45","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1093\/bioinformatics\/btw777","volume":"33","author":"DJ McCarthy","year":"2017","unstructured":"McCarthy, D. J., Campbell, K. R., Lun, A. T. L. & Wills, Q. F. Scater: pre-processing, quality control, normalization and visualization of single-cell RNA-seq data in R. Bioinformatics. 33, 1179\u20131186 (2017).","journal-title":"Bioinformatics."},{"key":"485_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"485_CR47","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/wics.51","volume":"2","author":"H Abdi","year":"2010","unstructured":"Abdi, H. Partial least squares regression and projection on latent structure regression (PLS Regression). WIREs Comput. Stat. 2, 97\u2013106 (2010).","journal-title":"WIREs Comput. Stat."},{"key":"485_CR48","first-page":"2122","volume":"5","author":"ATL Lun","year":"2016","unstructured":"Lun, A. T. L., McCarthy, D. J. & Marioni, J. C. A step-by-step workflow for low-level analysis of single-cell RNA-seq data with Bioconductor. F1000Research 5, 2122 (2016).","journal-title":"F1000Research"},{"key":"485_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-018-4772-0","volume":"19","author":"K Street","year":"2018","unstructured":"Street, K. et al. Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics. BMC Genom. 19, 477 (2018).","journal-title":"BMC Genom."},{"key":"485_CR50","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1080\/01621459.1951.10500769","volume":"46","author":"FJ Massey","year":"1951","unstructured":"Massey, F. J. The Kolmogorov-Smirnov test for goodness of fit. J. Am. Stat. Assoc. 46, 68\u201378 (1951).","journal-title":"J. Am. Stat. Assoc."}],"container-title":["npj Systems Biology and Applications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41540-024-00485-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41540-024-00485-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41540-024-00485-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T10:03:05Z","timestamp":1736503385000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41540-024-00485-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,10]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["485"],"URL":"https:\/\/doi.org\/10.1038\/s41540-024-00485-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4530110\/v1","asserted-by":"object"}]},"ISSN":["2056-7189"],"issn-type":[{"value":"2056-7189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,10]]},"assertion":[{"value":"4 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing non-financial interest. J.Z., W.Z., C.M., X.Y., M.H. declare the following competing financial interests: employees of Genentech Inc. or Roche and shareholders of Roche. All other authors declare no competing financial interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5"}}